May 20, 2003
Viragen (VRA) Files Patent Application For Drug To Target SARS
Viragen, Inc. today announced that it has filed a patent application covering the use of natural human leukocyte-derived alpha interferon for the treatment and prevention of severe acute respiratory syndrome (SARS).
Amazon Price:
Posted by Timothy Fredel at May 20, 2003 7:45 PM
Comments
Mike Furir Mike 54
Posted by: Mike Furir 343 at March 7, 2006 2:54 AMMike Furir Mike 667
Posted by: Mike Furir 532 at April 8, 2006 6:31 AMMike Furir Mike 168
Posted by: Mike Furir 948 at April 8, 2006 6:31 AMPost a comment
This is a test.